XBIOTECH INC. Payments for Construction in Process
XBIOTECH INC. (XBIT) reported Payments for Construction in Process of $9.17 million for the 12-month period ending 2016-12-31, per its 10-K/A filed 2019-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForConstructionInProcess · last filed 2019-03-15
- XBIOTECH INC. payments for construction in process for the quarter ending 2016-12-31 was $1.44M, a 57.52% decline year-over-year.
- XBIOTECH INC. payments for construction in process for the quarter ending 2016-09-30 was $2.56M, a 20.11% decline year-over-year.
- XBIOTECH INC. payments for construction in process for the quarter ending 2016-06-30 was $3.80M, a 256.62% increase year-over-year.
- XBIOTECH INC. payments for construction in process for the quarter ending 2016-03-31 was $1.37M, a 227.92% increase year-over-year.
- XBIOTECH INC. payments for construction in process for fiscal 2016 was $9.17M, a 13.61% increase from fiscal 2015.
- XBIOTECH INC. payments for construction in process for fiscal 2015 was $8.07M.
| Period end | Payments for Construction in Process 3 month | Payments for Construction in Process 6 month | Payments for Construction in Process 9 month | Payments for Construction in Process 12 month |
|---|---|---|---|---|
| 2016-12-31 | $1.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | $4.00M derived: sum of 2 quarters · filed 2019-03-15 | $7.79M derived: sum of 3 quarters · filed 2019-03-15 | $9.17M 10-K/A · filed 2019-03-15 |
| 2016-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $6.36M derived: sum of 2 quarters · filed 2016-11-14 | $7.73M 10-Q · filed 2016-11-14 | $11.11M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $5.17M 10-Q · filed 2016-08-12 | $8.55M derived: sum of 3 quarters · filed 2018-03-16 | $11.76M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $1.37M 10-Q · filed 2016-05-13 | $4.76M derived: sum of 2 quarters · filed 2018-03-16 | $7.96M derived: sum of 3 quarters · filed 2018-03-16 | $9.03M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $6.59M derived: sum of 2 quarters · filed 2018-03-16 | $7.65M derived: sum of 3 quarters · filed 2018-03-16 | $8.07M 10-K · filed 2018-03-16 |
| 2015-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $4.27M derived: sum of 2 quarters · filed 2016-11-14 | $4.69M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $1.48M 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | $419.00K 10-Q · filed 2016-05-13 | |||
| 2014-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $28.00K 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $14.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |